Cerebrolysin

Cerebrolysin is a porcine brain-derived neuropeptide preparation studied for neuroprotection, cognitive support, and neurologic recovery.

Profile · 01

Overview

Cerebrolysin is a porcine brain-derived peptide preparation containing low-molecular-weight neuropeptides and amino acids. It has regulatory use in some countries for neurologic indications, but it is not FDA-approved in the United States.

Human studies have explored it in dementia and stroke recovery, while most route-specific clinical experience involves intravenous administration rather than the subcutaneous adaptation described in the markdown source. This page presents that source as an educational research summary.

At a Glance

Goal
Support neuroprotection, cognitive recovery, and neurotrophic signaling
Categories
NeuroprotectionCognitive SupportNeurorecoveryBrain Health
Synergistic
Semax · Selank · Dihexa · P21
Profile · 02

Protocol

Suggested daily titration approach starting with once-daily dosing and then discussing split higher-dose administration.

Reconstitute
Add 3.0 mL bacteriostatic water to a 60 mg vial for about 20 mg/mL concentration
Typical daily range
20-32 mg daily
Start
20 mg once daily during Week 1
Target
28-32 mg daily by Weeks 3-4+
Frequency
Daily; higher-dose phases are commonly discussed as split AM/PM dosing
Cycle Length
8-12 weeks; optional extension to 16 weeks
Timing
Use consistent timing and rotate injection sites
Route
Subcutaneous
Cycle
8-12 weeks on, 4 weeks off

This page tracks total daily dose even though the source recommends splitting larger totals into AM/PM injections from Week 2 onward. That split-dose logistics note matters because the daily volumes are large for subcutaneous administration. Most human evidence for Cerebrolysin comes from IV rather than subcutaneous protocols.

Dose progression

Week 1
20 mg · 100 units once daily
Week 2
24 mg · Often split into 2 injections
Week 3
28 mg · Often split into 2 injections
Week 4+
32 mg · Often split into 2 injections

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Science · 01

How Cerebrolysin works.

Cerebrolysin contains enzymatically processed porcine brain proteins that yield neuropeptides and amino acids with neurotrophic-factor-like activity. The literature often compares its effects to endogenous NGF and BDNF signaling as well as broader anti-inflammatory and neuroregenerative pathways.

Human clinical studies have examined Cerebrolysin in dementia and stroke recovery with mixed but sometimes favorable results. Most of that evidence is tied to intravenous use, which limits how directly it transfers to subcutaneous adaptation.

Science · 02

Effects

Observations from clinical or preclinical literature.

Preclinical models support neuroprotection and improved recovery after ischemic injury
Some human dementia studies describe modest cognitive benefit
Stroke-recovery results are mixed but positive findings have been reported in some settings
Generally well tolerated in short-term clinical use
Mild injection-site reactions may occur with subcutaneous administration
Dizziness, headache, or GI upset are occasionally reported
Science · 03

Caution

Avoid in those with known allergy to porcine-derived products
Not recommended during pregnancy or breastfeeding because safety data is insufficient
Use caution in seizure disorders and significant renal impairment
Consult a qualified healthcare provider before use if you have chronic neurologic or other complex medical conditions

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Lifestyle · 01

CoFactors

Omega-3 fatty acids
Support neuronal membrane integrity and complement neurotrophic goals.
B vitamins
Support methylation and broader neurologic function.
Magnesium
Supports synaptic plasticity and neuromuscular function.
Vitamin D
Associated with broader neuroprotective and cognitive-health signaling.
Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Use a nutrient-dense diet with adequate omega-3 fats and B vitamins
Maintain regular aerobic activity and cognitive stimulation where appropriate
Prioritize 7-9 hours of sleep to support neurorecovery goals
Limit excessive alcohol and other neurotoxic exposures
Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Cognitive function - track memory, focus, and processing speed over time
  2. Sleep quality - useful for overall neurologic recovery
  3. Mood and energy - monitor daily trends during the cycle
  4. Injection-site reactions and tolerability - especially important if split dosing is used
Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

CBC (Complete Blood Count)
General monitoring and baseline screening.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during peptide use.
Vitamin B12 and folate
Useful neurologic cofactors to monitor.
Homocysteine
Relevant when broader cognitive-health optimization is part of the goal.
CRP (C-Reactive Protein)
General inflammation marker.
Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 60 mg each…
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe
Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mg/mL
Volume per dose
0mL
…
Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.
Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
If splitting the dose, use different injection sites for each administration
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.
Reference · 01

Notes

Use a new sterile syringe for each injection and dispose of it safely
Weeks 2+ are often discussed as split-dose phases even though the calculator tracks total daily dose
Large subcutaneous volumes may reduce practicality and tolerability
Most human data are from IV protocols, not subcutaneous delivery
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.
Reference · 02

References

  1. Medical Science Monitor
    Meta-analytic and clinical literature on Cerebrolysin in stroke recovery.
    https://pubmed.ncbi.nlm.nih.gov/
  2. PLOS ONE
    Preclinical neuroprotective Cerebrolysin work in ischemia models.
    https://journals.plos.org/plosone/
  3. Alzheimer's Drug Discovery Foundation
    Cognitive Vitality report on Cerebrolysin.
    https://www.alzdiscovery.org/
  4. Ever Neuro Pharma
    Product and storage guidance for Cerebrolysin formulations.
    https://www.everpharma.com/
  5. CDC
    Subcutaneous injection route guidance.
    https://www.cdc.gov/vaccines/hcp/admin/downloads/YCTS-VaxAdmin-Subcut-injection.pdf
  6. WHO (NCBI Bookshelf)
    Injection-safety guidance for subcutaneous administration.
    https://www.ncbi.nlm.nih.gov/books/NBK390474/
On this page